Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyradiculoneuritis following botulinum toxin therapy.

B A Haug1, D Dressler, H W Prange

  • 1Neurologische Universitätsklinik, Göttingen, Federal Republic of Germany.

Journal of Neurology
|February 1, 1990
PubMed
Summary

Guillain-Barré syndrome developed in a patient after botulinum toxin type A injections for blepharospasm. This case suggests a potential link between the toxin and neurological adverse events, warranting further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.

BMJ case reports·2025
Same author

Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients.

Parkinson's disease·2020
Same author

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.

Journal of neural transmission (Vienna, Austria : 1996)·2019
Same author

Validating the Parkinson's disease caregiver burden questionnaire (PDCB) in German caregivers of advanced Parkinson's disease patients.

International psychogeriatrics·2019
Same author

[Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].

Der Nervenarzt·2018
Same author

Impaired heart rate variability in cervical dystonia is associated to depression.

Journal of neural transmission (Vienna, Austria : 1996)·2016

Area of Science:

  • Neuroscience
  • Toxicology
  • Immunology

Background:

  • Idiopathic blepharospasm is a focal dystonia treated with botulinum toxin type A.
  • Botulinum toxin type A targets neuromuscular junctions, inhibiting acetylcholine release.

Observation:

  • A patient developed Guillain-Barré syndrome following bilateral orbicularis oculi injections of botulinum toxin type A.
  • The patient's idiopathic blepharospasm was successfully treated prior to neurological symptom onset.

Findings:

  • A potential causal relationship between botulinum toxin type A and Guillain-Barré syndrome is hypothesized.
  • The study considers existing literature on adverse effects of vaccinations and Clostridium botulinum toxin.

Implications:

Related Experiment Videos

  • This case highlights a rare but serious potential neurological adverse effect of botulinum toxin type A.
  • Further research is needed to elucidate the mechanisms underlying this association and inform clinical practice.